Liminatus Pharma, Inc. (NASDAQ: LIMN) has its forward price-to-earnings ratio published. This valuation metric provides investors with insight into the company's earnings potential relative to its share price.
Liminatus Pharma Reports Forward Price-to-Earnings Ratio
|1 min read
Liminatus PharmaLIMNP/E RatioValuationBiotech